cbdMD (YCBD) EBIT Margin: 2016-2025
Historic EBIT Margin for cbdMD (YCBD) over the last 10 years, with Sep 2025 value amounting to -11.27%.
- cbdMD's EBIT Margin fell 758.00% to -14.53% in Q3 2025 from the same period last year, while for Sep 2025 it was -11.27%, marking a year-over-year increase of 537.00%. This contributed to the annual value of -11.27% for FY2025, which is 537.00% up from last year.
- According to the latest figures from FY2025, cbdMD's EBIT Margin is -11.27%, which was up 32.28% from -16.64% recorded in FY2024.
- Over the past 5 years, cbdMD's EBIT Margin peaked at -11.27% during FY2025, and registered a low of -210.83% during FY2022.
- Over the past 3 years, cbdMD's median EBIT Margin value was -16.64% (recorded in 2024), while the average stood at -39.22%.
- Its EBIT Margin has fluctuated over the past 5 years, first tumbled by 16,939bps in 2022, then skyrocketed by 12,108bps in 2023.
- Over the past 5 years, cbdMD's EBIT Margin (Yearly) stood at -41.44% in 2021, then plummeted by 16,939bps to -210.83% in 2022, then surged by 12,108bps to -89.76% in 2023, then skyrocketed by 7,312bps to -16.64% in 2024, then skyrocketed by 537bps to -11.27% in 2025.